Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and ...

Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for-60 reverse stock split that will take effect on Friday at 5 p.m. In a ...

Shares of NASDAQ:BNGO opened at $3.36 on Wednesday. Bionano Genomics has a 52-week low of $2.68 and a 52-week high of $72.60. The stock has a market cap of $9.18 million, a P/E ratio of -0.02 and a ...

Bionano Genomics (NASDAQ:BNGO) Stock, Option Chain Option chain shows key data for Bionano Genomics's stock options at various strike prices and expiration dates. Traders use this information to ...

Stock futures dipped Thursday morning as investors weighed early developments in the US-China trade war, with attention now turning to upcoming inflation data and potential monetary policy signals ...

Bionano Genomics (NASDAQ:BNGO) lost ~9% premarket Friday after the life sciences company announced an agreement with certain healthcare-focused institutional investors to sell ~17.5M shares of its ...

Bionano Genomics BNGO is set to give its latest quarterly earnings report on Thursday, 2025-08-14. Here's what investors need to know before the announcement. Analysts estimate that Bionano Genomics ...